Therefore, after knockout of the IBD risk allele CARD9, it was observed that the metabolism of tryptophan decreased in mice, and it was difficult to catalyze tryptophan into AhR ligands, resulting in reduced release of IL-22 factors, making mice more susceptible to DSS-induced IBD. The gene discussed is IL22; the disease is inflammatory bowel disease.